Advanced BioNutrition Receives MdBio Grant to Commercialize Novel Microencapsulation Technology.Business Editors/Biotech Writers COLUMBIA, Md.--(BUSINESS WIRE)--Feb. 24, 2004 Advanced BioNutrition Corp. (ABN), a leader in developing functional nutrition technology to improve animal health and human nutrition, announced that it has received a $200,000 award from MdBio for scaleup and commercialization of ABN's novel microencapsulation microencapsulation a manufacturing process in which an active agent is contained in microcapsules, suspended in a liquid. As the vehicle dries, the capsules dry out and the contents become active. technology. ABN's technology is designed to provide targeted delivery of probiotics Probiotics Bacteria that are beneficial to a person's health, either through protecting the body against pathogenic bacteria or assisting in recovery from an illness. Mentioned in: Colonic Irrigation, Dysentery, Gastroenteritis and bioactive compounds to the site of activity in the guts of aquatic animals, using all GRAS GRAS - A public domain graph-oriented database system for software engineering applications from RWTH Aachen. (Generally Recognized As Safe Generally Recognized as Safe (GRAS) is a United States of America Food and Drug Administration (FDA) designation that a chemical or substance added to food is considered safe by experts, and so is exempted from the usual Federal Food, Drug, and Cosmetic Act (FFDCA) food ) food-grade materials. Probiotics are "friendly" bacteria that prevent the growth of pathogenic bacteria and can alleviate the need for antibiotic treatment. Beneficial bioactive compounds are normally destroyed in the harsh environment of the stomach before they reach the intestines, where they can prevent the growth of pathogenic bacteria. ABN's microencapsulation process protects these helpful bacteria and enables their release to targeted areas of the gastrointestinal tract. ABN's microencapsulation technology provides a revolutionary new method to deliver easily degraded compounds such as vaccines, enzymes and other nutraceutical products in a bioactive form. "We are very excited about the potential of this new technology to produce healthier and safer seafood products," said David J. Kyle, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of ABN. "Our novel microencapsulation technology could also enable the development of a new generation of probiotic pro·bi·ot·ic n. A dietary supplement containing live bacteria or yeast that supplements normal gastrointestinal flora, given especially after depletion of flora caused by infection or ingestion of an antibiotic drug. products for human consumption." Work under this project, titled "Commercial Production of Targeted Probiotic MicroCapsules for Aquatic Animals," will be conducted by ABN at its own laboratories, in conjunction with the Maryland Technology Enterprise Institute at the University of Maryland University of Maryland can refer to:
About MdBio MdBio, Inc. is a private, non-profit corporation that offers a variety of programs to advance the commercial development of bioscience in Maryland. About ABN Advanced BioNutrition is a leader in developing functional nutrition technology to improve animal health and human nutrition. The company is headquartered in Columbia, MD. www.abn-corp.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion